Living with diabetes often means living with uncertainty. When will my blood sugar drop? Am I safe during the night? How much time do I have to react? Now, thanks to a collaboration between IBM and Roche, there’s a promising new answer: artificial intelligence.

What’s the innovation?

The two companies have launched Accu-Chek SmartGuide Predict, an AI-powered app that helps people with diabetes stay ahead of their condition. By using real-time data from a wearable sensor, the app can forecast blood glucose trends up to two hours in advance.

What makes it especially powerful is its ability to warn users 30 minutes before a potential hypoglycemic event—crucial for preventing dangerous drops, especially during sleep.

How does it work?

The system uses IBM’s watsonx AI platform to analyze the data coming from glucose sensors. Based on this, the app delivers personalized alerts and predictions tailored to the user’s daily patterns and trends.

In clinical trials, the system showed strong accuracy, with a mean absolute relative difference (MARD) of just 9.2%, indicating reliable readings compared to lab results.

Where is it available?

Currently, Accu-Chek SmartGuide Predict is available in Switzerland, with plans to expand into more European countries soon.

Why does it matter?

This technology gives people with diabetes greater control, confidence, and peace of mind. By predicting dangerous drops before they happen, users can take action early—improving both their safety and overall quality of life.

AI is no longer just about the future—it’s actively improving lives today. And for millions living with diabetes, this might be one of the most meaningful steps yet.